The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway
Nowadays potential preclinical drugs for the treatment of nonalcoholic steatohepatitis (NASH) have failed to achieve expected therapeutic efficacy because the pathogenic mechanisms are underestimated. Inactive rhomboid protein 2 (IRHOM2), a promising target for treatment of inflammation-related dise...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522005007 |
| _version_ | 1811154381393887232 |
|---|---|
| author | Minxuan Xu Jun Tan Liancai Zhu Chenxu Ge Wei Dong Xianling Dai Qin Kuang Shaoyu Zhong Lili Lai Chao Yi Qiang Li Deshuai Lou Linfeng Hu Xi Liu Gang Kuang Jing Luo Jing Feng Bochu Wang |
| author_facet | Minxuan Xu Jun Tan Liancai Zhu Chenxu Ge Wei Dong Xianling Dai Qin Kuang Shaoyu Zhong Lili Lai Chao Yi Qiang Li Deshuai Lou Linfeng Hu Xi Liu Gang Kuang Jing Luo Jing Feng Bochu Wang |
| author_sort | Minxuan Xu |
| collection | DOAJ |
| description | Nowadays potential preclinical drugs for the treatment of nonalcoholic steatohepatitis (NASH) have failed to achieve expected therapeutic efficacy because the pathogenic mechanisms are underestimated. Inactive rhomboid protein 2 (IRHOM2), a promising target for treatment of inflammation-related diseases, contributes to deregulated hepatocyte metabolism-associated nonalcoholic steatohepatitis (NASH) progression. However, the molecular mechanism underlying Irhom2 regulation is still not completely understood. In this work, we identify the ubiquitin-specific protease 13 (USP13) as a critical and novel endogenous blocker of IRHOM2, and we also indicate that USP13 is an IRHOM2-interacting protein that catalyzes deubiquitination of Irhom2 in hepatocytes. Hepatocyte-specific loss of the Usp13 disrupts liver metabolic homeostasis, followed by glycometabolic disorder, lipid deposition, increased inflammation, and markedly promotes NASH development. Conversely, transgenic mice with Usp13 overexpression, lentivirus (LV)- or adeno-associated virus (AAV)-driven Usp13 gene therapeutics mitigates NASH in 3 models of rodent. Mechanistically, in response to metabolic stresses, USP13 directly interacts with IRHOM2 and removes its K63-linked ubiquitination induced by ubiquitin-conjugating enzyme E2N (UBC13), a ubiquitin E2 conjugating enzyme, and thus prevents its activation of downstream cascade pathway. USP13 is a potential treatment target for NASH therapy by targeting the Irhom2 signaling pathway. |
| first_indexed | 2024-04-10T04:14:37Z |
| format | Article |
| id | doaj.art-2496923f2e6942078d6f996b083ac336 |
| institution | Directory Open Access Journal |
| issn | 2211-3835 |
| language | English |
| last_indexed | 2024-04-10T04:14:37Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj.art-2496923f2e6942078d6f996b083ac3362023-03-12T04:21:06ZengElsevierActa Pharmaceutica Sinica B2211-38352023-03-0113310711092The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathwayMinxuan Xu0Jun Tan1Liancai Zhu2Chenxu Ge3Wei Dong4Xianling Dai5Qin Kuang6Shaoyu Zhong7Lili Lai8Chao Yi9Qiang Li10Deshuai Lou11Linfeng Hu12Xi Liu13Gang Kuang14Jing Luo15Jing Feng16Bochu Wang17Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, China; Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China; Corresponding authors.Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, China; Corresponding authors.Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, China; Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, ChinaShandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, China; Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaChongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, China; College of Modern Health Industry, Chongqing University of Education, Chongqing 400067, ChinaKey Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, ChinaKey Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China; Corresponding authors.Nowadays potential preclinical drugs for the treatment of nonalcoholic steatohepatitis (NASH) have failed to achieve expected therapeutic efficacy because the pathogenic mechanisms are underestimated. Inactive rhomboid protein 2 (IRHOM2), a promising target for treatment of inflammation-related diseases, contributes to deregulated hepatocyte metabolism-associated nonalcoholic steatohepatitis (NASH) progression. However, the molecular mechanism underlying Irhom2 regulation is still not completely understood. In this work, we identify the ubiquitin-specific protease 13 (USP13) as a critical and novel endogenous blocker of IRHOM2, and we also indicate that USP13 is an IRHOM2-interacting protein that catalyzes deubiquitination of Irhom2 in hepatocytes. Hepatocyte-specific loss of the Usp13 disrupts liver metabolic homeostasis, followed by glycometabolic disorder, lipid deposition, increased inflammation, and markedly promotes NASH development. Conversely, transgenic mice with Usp13 overexpression, lentivirus (LV)- or adeno-associated virus (AAV)-driven Usp13 gene therapeutics mitigates NASH in 3 models of rodent. Mechanistically, in response to metabolic stresses, USP13 directly interacts with IRHOM2 and removes its K63-linked ubiquitination induced by ubiquitin-conjugating enzyme E2N (UBC13), a ubiquitin E2 conjugating enzyme, and thus prevents its activation of downstream cascade pathway. USP13 is a potential treatment target for NASH therapy by targeting the Irhom2 signaling pathway.http://www.sciencedirect.com/science/article/pii/S2211383522005007Usp13Irhom2NASHHepatosteatosisUbc13NAFLD |
| spellingShingle | Minxuan Xu Jun Tan Liancai Zhu Chenxu Ge Wei Dong Xianling Dai Qin Kuang Shaoyu Zhong Lili Lai Chao Yi Qiang Li Deshuai Lou Linfeng Hu Xi Liu Gang Kuang Jing Luo Jing Feng Bochu Wang The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway Acta Pharmaceutica Sinica B Usp13 Irhom2 NASH Hepatosteatosis Ubc13 NAFLD |
| title | The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway |
| title_full | The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway |
| title_fullStr | The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway |
| title_full_unstemmed | The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway |
| title_short | The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway |
| title_sort | deubiquitinating enzyme 13 retards non alcoholic steatohepatitis via blocking inactive rhomboid protein 2 dependent pathway |
| topic | Usp13 Irhom2 NASH Hepatosteatosis Ubc13 NAFLD |
| url | http://www.sciencedirect.com/science/article/pii/S2211383522005007 |
| work_keys_str_mv | AT minxuanxu thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT juntan thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT liancaizhu thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT chenxuge thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT weidong thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT xianlingdai thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT qinkuang thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT shaoyuzhong thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT lililai thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT chaoyi thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT qiangli thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT deshuailou thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT linfenghu thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT xiliu thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT gangkuang thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT jingluo thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT jingfeng thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT bochuwang thedeubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT minxuanxu deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT juntan deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT liancaizhu deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT chenxuge deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT weidong deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT xianlingdai deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT qinkuang deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT shaoyuzhong deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT lililai deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT chaoyi deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT qiangli deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT deshuailou deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT linfenghu deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT xiliu deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT gangkuang deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT jingluo deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT jingfeng deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway AT bochuwang deubiquitinatingenzyme13retardsnonalcoholicsteatohepatitisviablockinginactiverhomboidprotein2dependentpathway |